CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma F Cimmino et al, 2016, Oncogenesis CrossRef
The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer Ping Zhao et al, 2019, BMC Cancer CrossRef
Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles null Cruz et al, 2019, Cancers CrossRef
Bispecific Complement Engagers for Targeted Complement Activation Dennis V. Pedersen et al, 2023, The Journal of Immunology CrossRef
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention Zvi Fishelson et al, 2019, Frontiers in Immunology CrossRef
Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical Chao Tang et al, 2022, Clinical and Translational Oncology CrossRef
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers Yasmine Lounici et al, 2022, Cancers CrossRef
Applicability of Traditional In Vitro Toxicity Tests for Assessing Adverse Effects of Monoclonal Antibodies: A Case Study of Rituximab and Trastuzumab Arathi Kizhedath et al, 2018, Antibodies CrossRef
Improvement of Antibody Activity by Controlling Its Dynamics Using the Glycan–Lectin Interaction Yoshiyuki Manabe et al, 2023, Angewandte Chemie CrossRef
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe? Maryam Sadri et al, 2023, International Immunopharmacology CrossRef
Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations Ralph E. Parchment et al, 2016, Seminars in Oncology CrossRef
New perspectives on complement mediated immunotherapy Grzegorz Stasiłojć et al, 2016, Cancer Treatment Reviews CrossRef
Formulation of patient dose of [177Lu]Lu‐Trastuzumab using in‐house developed freeze‐dried kit: A path forward for clinical translation Jeyachitra Amirdhanayagam et al, 2024, Journal of Labelled Compounds and Radiopharmaceuticals CrossRef
Improvement of Antibody Activity by Controlling Its Dynamics Using the Glycan–Lectin Interaction Yoshiyuki Manabe et al, 2023, Angewandte Chemie International Edition CrossRef
Membrane-Bound Complement Regulatory Proteins in Breast Cancer: Are They Best Therapeutic Targets? Sofia Álvarez-Lorenzo et al, 2023, Breast Cancer Updates CrossRef
Complement system's role in cancer and its therapeutic potential in ovarian cancer H. Bareke et al, 2018, Scandinavian Journal of Immunology CrossRef
CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity Yu Wang et al, 2017, Oncology Letters CrossRef
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer Xiaoyong Fu et al, 2023, Cell Reports CrossRef
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis Li-Chung Tsao et al, 2022, JCI Insight CrossRef
Effect of IL-6 and IL-8 on the expression of the complement activation inhibitors MAC-inhibitory protein and decay-accelerating factor in ovarian cancer A2780 cells Lucyna Kapka-Skrzypczak et al, 2016, Oncology Letters CrossRef
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
Yao Chen et al, 2020, International Journal of Nanomedicine CrossRef
The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer QIANWEN OUYANG et al, 2016, International Journal of Oncology CrossRef
Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways Soon Park et al, 2023, Oncology Letters CrossRef
FHR4‐based immunoconjugates direct complement‐dependent cytotoxicity and phagocytosis towards HER2‐positive cancer cells Carole Seguin‐Devaux et al, 2019, Molecular Oncology CrossRef
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs Josée Golay et al, 2020, Antibodies CrossRef